Atrial natriuretic peptide, released by mammalian atria in response to volume overload, induces vasodilation and natriuresis. In this study, a direct effect on cardiac mechanical performance was demonstrated. Atriopeptin HI (10~'-10~7 M) induced early relaxation and decreased peak twitch of isometric and isotonic twitches of isolated papillary muscles of cat and rat, without affecting maximal unloaded velocity of shortening. This effect resembled the effects of dibutyryl cyclic GMP and of sodium nitroprusside on cardiac muscle. The action of atriopeptin III, but not of dibutyryl cyclic GMP or sodium nitroprusside, was abolished by mechanically or chemically damaging the endocardial endothelial surface. Thus, the early relaxation of cardiac muscle induced by atrial natriuretic peptide may be mediated through receptors on the endocardial endothelium. (Circulation Research 1988:62;1171-1174 M ammalian atrial myocytes contain granules 1 -2 that, in response to volume overload, release the atrial natriuretic peptide (ANP). 3~5 ANP induces arterial hypotension, 6 -7 ascribed to vasorelaxant and natriuretic properties. 8 -9 High plasma concentrations of ANP have been measured not only in the coronary sinus but also in both right and left cardiac chambers, suggesting release of ANP through Thebesian veins. 10 "
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Atrial natriuretic peptide, released by mammalian atria in response to volume overload, induces vasodilation and natriuresis. In this study, a direct effect on cardiac mechanical performance was demonstrated. Atriopeptin HI (10~'-10~7 M) induced early relaxation and decreased peak twitch of isometric and isotonic twitches of isolated papillary muscles of cat and rat, without affecting maximal unloaded velocity of shortening. This effect resembled the effects of dibutyryl cyclic GMP and of sodium nitroprusside on cardiac muscle. The action of atriopeptin III, but not of dibutyryl cyclic GMP or sodium nitroprusside, was abolished by mechanically or chemically damaging the endocardial endothelial surface. Thus, the early relaxation of cardiac muscle induced by atrial natriuretic peptide may be mediated through receptors on the endocardial endothelium. (Circulation Research 1988:62; 1171 -1174 M ammalian atrial myocytes contain granules 1 -2 that, in response to volume overload, release the atrial natriuretic peptide (ANP). 3~5 ANP induces arterial hypotension, 6 -7 ascribed to vasorelaxant and natriuretic properties. 8 -9 High plasma concentrations of ANP have been measured not only in the coronary sinus but also in both right and left cardiac chambers, suggesting release of ANP through Thebesian veins. 10 "
A direct action of ANP on cardiac performance has not yet been demonstrated. Therefore, we studied the effects of atriopeptin III on the mechanical performance of isolated ventricular cardiac muscle. Because dense receptors for ANP have been observed on the ventricular endocardial endothelium' 2 and we have recently demonstrated that this latter structure controls the mechanical performance of the underlying myocardium, 13 the effects of ANP were examined on papillary muscles, with either intact or damaged endocardial endothelium. The findings have been reported recently in part. 14 
Materials and Methods
Papillary muscles (n = 40) were isolated from cat right ventricle. Because diet salt and water intake influence synthesis, storage, and release of ANP, 15 the animals were deprived of water for 24-48 hours before the experiment. The muscles were mounted vertically in an organ bath filled with a physiological salt solution, gassed with 95% O 2 -5% CO 2 , and containing (mM) NaCl 118, KC1 4.7, MgSO 4 -7H 2 O 1.2, KH 2 PO 4 1.2, CaCl 2 -6H 2 O 1.25, NaHCO 3 25, glucose 4.5; pH was 7.4 and temperature was 35° C. The lower end of the muscle was held by a phosphor-bronze clip, and the upper tendinous end was connected to an electro-magnetic force-length transducer 13 with a Tevdek 7.0 breaded thread. All experiments were performed at L^, that is, the muscle length at which active force development was maximal, and after a 2-3-hour stabilization period. The papillary muscles were stimulated at 0.2 Hz and at 10% above threshold through a pair of platinum plate electrodes. The contractile properties were derived from 1) a preloaded isotonic twitch and 2) an isometric twitch at \ mMX . Maximal velocity of shortening at zero load ( V m ) was obtained by abruptly unloading the stimulated muscle to zero load after the latency period. To eliminate the effect of the muscle's memory for length and load during the preceding twitches, all test twitches were separated by a series of at least eight preloaded isotonic twitches at l^.
Atriopeptin III (10" 9 , 10" 8 , and 10~7 M) (24-amino acid synthetic ANP, rat sequence), 5 dibutyryl cyclic GMP (db-cGMP, 10" 6 or 10" 5 M; Sigma Chemical, St. Louis, Missouri), and sodium nitroprusside (10~6 M; Roche Laboratories, Nutley, New Jersey) were added from stock solutions and measurements were made after stabilization. The drugs were dissolved in distilled water and only a maximum of 50 /xl of that solution was added to the 50-ml bathing solution; adding the same amount of distilled water to the bathing solution had no effect on the muscle. Sodium nitroprusside was studied in a darkened chamber to prevent degradation.
Drug effects were studied in control muscles with intact endocardial surface (n = 21) and in a different group of muscles after damaging the endocardial endothelial surface (n=\9). While in working position, these latter muscles were either immersed for 1 second in 1 % Triton X-100 dissolved in Krebs-Ringer solution at 35° C, or the endocardial surface was gently rubbed with a plastic blade, a procedure that took about 30 seconds. 13 Scanning and transmission electron micrographs confirmed the presence of an intact endocardial monolayer in control muscles. After a 1-second Triton X-100 exposure, the endothelial cells typically showed numerous pores in the membrane, often with retraction of the cells. After gentle rubbing, large areas of denuded collagen fibers could be seen. Neither light micrographs nor transmission electronmicrographs showed any damage to the underlying myocardial muscle cells. 13
Results

Effect of Atriopeptin III
In a dose-dependent manner between 10~9 and 10~7 M, atriopeptin III induced early relaxation of isometric and isotonic twitches with a significant reduction of the time to half tension decline in the isometric twitch and of the time to peak relaxation rate in the isotonic twitch (Figures 1 and 2) . Concomitantly with the early onset of relaxation, time to peak twitch tension and to peak shortening were shortened and accompanied by a significant decrease in peak twitch performance. Initial velocity of twitch contraction and maximal unloaded velocity of shortening were not affected. Differences in the duration of water deprivation of the animals may explain some of the variations in response to atriopeptin III.
In papillary muscles (n = 6) from the left ventricle of the rat, a similar phenomenon was observed. These rat cardiac muscles were, however, not included in this study. 14 
Comparison With db-cGMP and Sodium Nitroprusside
In other tissues, the intracellular actions of ANP have been associated with a rise in cyclic GMP (cGMP). 16 Therefore, we studied the effects of db-cGMP, lO-MO" 5 M, a cGMP analogue known to cross cell membranes, 17 and of sodium nitroprusside (SN), 10~6 M, a drug that increases intracellular cGMP. 18 For both drugs, measurements were made after 15 minutes of stabilization. In cat papillary muscle (n= 12), both of these drugs induced early twitch relaxation (Figure 3) , similar to the effect after atriopeptin III, with a statistically significant decrease in time to peak twitch, in peak twitch performance, and in half twitch relaxation time.
Effects After Damaging Endocardial Surface
Damaging the endocardial endothelium, either by gentle rubbing or by brief exposure to 1% Triton X-100, irreversibly decreased peak twitch tension, peak twitch shortening, and the time to peak twitch and to half relaxation. 13 This intervention abolished the response of cat papillary muscle (n = 7) to atriopeptin III (Figure 3) . A small effect of atriopeptin III on relaxation could still be observed in one preparation but not in the other six. By contrast, the effects of db-cGMP (n = 6) and of SN (n = 6) were unaffected (Figure 3 , Table 1 ).
Discussion
Atriopeptin III decreased peak twitch due to early twitch relaxation in isolated ventricular muscle of cat and rat without affecting V^,. This particular type of modulation of cardiac performance is very akin to the modulation that was recently shown to be mediated through the endocardial endothelial surface. l3 Since, in addition, the effects of atriopeptin HI were abolished by damaging the endocardial endothelial surface, this could mean that, at least in cat and rat ventricle, atriopeptin III would act on the myocardium through receptors on the endocardial endothelium.
How the endocardial endothelial monolayer controls myocardial performance is as yet somewhat speculative. 13 Either a transendothelial physico-chemical gradient or a receptor-induced release of substances by the endocardial endothelial cells, or both, could be involved. Preliminary data suggest that a transendothelial physico-chemical gradient may exist and that perhaps through electrotonic coupling it would control the sarcolemmal properties of the myocardium. Its role in the action of atriopeptin III needs further investigation. With respect to the possibility of a receptor-induced control, endocardial ANP receptors have been described in rat heart. 12 These receptors could mediate the observed response, possibly through release of a "relaxant factor." In analogy with the vascular endothelium-derived relaxing factor and given the resemblance of the effect of atriopeptin III on the myocardium with cGMP and nitroprusside, an intracellular m FIGURE 1. Representative example of the effect of atriopeptin III, IO~9-IO~7 M, on twitches of cat papillary muscle (35° C, 1.25 mM Ca 2 *). Twitches after addition of atriopeptin III are typically decreased. Characteristics of cat papillary muscle at l max : length, 8 mm; mean cross-sectional area (assuming cylindrical shape and specific gravity of1), 0.65 mm 2 ; resting tension, 6.2 mNImm 2 ; ratio of resting tension to total tension of the isometric twitch at l mal (RT/TT), 8%. increase in cGMP in the cardiac muscle cells could perhaps participate. The observation, in one muscle, of a small residual response to ANP after 1% Triton X-100 is not contradictory; due to the limited exposure time, parts of the endothelium may still have some functional receptors. In cat cardiac tissue, ANP receptors have however not yet been studied.
As the relaxant effect of atriopeptin III on ventricular cardiac muscle would induce early pressure fall and early rapid ventricular filling in the intact heart, it may represent an adjustment of the heart to volume overload. In addition, the decrease in peak twitch tension and shortening could contribute to the observed decrease in cardiac output in intact animals. Along with the observation that atriopeptin II may induce coronary vasoconstriction, 19 these findings could also imply that the hypotensive effect of ANP 6 7 2 0 may result in part from changes in peak ventricular performance. Twitches after addition of the drug are typically decreased. Left panel: intact muscle; right panel: after a 1-second exposure to 1% Triton X-100. After damaging the endocardial endothelium, the response to atriopeptin III is abolished, but the response to db-cGMP and sodium nitroprusside is unaffected.
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